Mirum Pharmaceuticals Inc Stock, NASDAQ:MIRM
950 Tower Lane, Suite 1050, Foster City, California 94404
United States of America
Number of Employees: 68
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its product candidates include Maralixibat and Volixibat. The company was founded by Niall O'Donnel, Michael Grey and Christopher Peetz on May 7, 2018 and is headquartered in Foster City, CA.